Skip to main content
. Author manuscript; available in PMC: 2017 Apr 15.
Published in final edited form as: Bioorg Med Chem Lett. 2016 Mar 2;26(8):2030–2034. doi: 10.1016/j.bmcl.2016.02.085

Table 1.

IC50 Values for New Triazine Analogues.

Name of Compound Formula Weight OV 90 A2780 MCF-7 MDA-MB231 A549 H1299 HT-29
TZ9 366.3 60 7.8 5 4.6 7.2 45 8.3
3a 245.24 75 7.3 5.9 2.6 7.8 65 3.3
3b 275.27 80 14.7 6.2 7.6 5.2 65 5.4
3c 259.27 60 5.5 16 12.7 9.3 40 4.5
3d 275.27 90 5.6 11.8 15.7 7.5 50 8.6
3e 279.69 85 36.6 8.8 24.6 7.5 30 4.6
6a 397.43 8 7.1 6 2.5 14.6 11 9.5
6b 457.48 12 6.3 7.2 4.2 10.8 5 5.8
6c 425.49 5 3.6 4.2 3.5 11.6 22 5.2
6d 457.48 10 5 7.2 3.9 6.9 26 8.9
6e 466.32 60 8.2 4.2 3.5 7.8 15 4.1

As described in the methods, the MTS assay was used to evaluate cell survival in the presence of each new triazine analogue in the range of 0 to 125 μM concentrations. For each cell line, the MTS assays were performed at least three independent experiments and each time in triplicates. The results presented in the table are average values from multiple experiments. The IC50 values were calculated from the data of % survival vs. drug concentration using Microsoft Excel 2010.